artemisinin has been researched along with Disease, Pulmonary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheong, DHJ; Tan, DWS; Tran, T; Wong, FWS | 1 |
| Deng, C; Guan, X; Guo, J; Jin, C; Li, G; Li, H; Song, J; Tang, Y; Wang, Q; Xie, F; Xu, Q; Yu, W; Yuan, M; Yuan, Y; Zhang, H; Zou, Y | 1 |
1 review(s) available for artemisinin and Disease, Pulmonary
| Article | Year |
|---|---|
Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases.
Topics: Antiviral Agents; Artemisinins; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Lung Diseases; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
1 trial(s) available for artemisinin and Disease, Pulmonary
| Article | Year |
|---|---|
Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial.
Topics: Adult; Antiviral Agents; Artemisinins; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Long QT Syndrome; Lung Diseases; Male; Middle Aged; Quinolines; RNA, Viral; SARS-CoV-2; Viral Load | 2021 |